Filing Details

Accession Number:
0001493152-11-000153
Form Type:
5
Zero Holdings:
No
Publication Time:
2011-05-13 18:03:47
Reporting Period:
2010-12-31
Filing Date:
2011-05-13
Accepted Time:
2011-05-13 18:03:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1368286 Itech Medical Inc. IMSU Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1368286 Itech Medical, Inc. 23 Valley Trail
Newmarket OR L3Y 4V8
Chief Financial Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Disposition 2009-03-26 10,000 $0.30 7,819,549 No 4 P Indirect By Corporation
Common Stock, Par Value $0.0001 Per Share Disposition 2009-09-09 100,549 $0.30 7,719,000 No 4 P Indirect By Corporation
Common Stock, Par Value $0.0001 Per Share Disposition 2009-10-12 15,000 $0.61 7,704,000 No 4 P Indirect By Corporation
Common Stock, Par Value $0.0001 Per Share Disposition 2010-01-22 29,000 $0.27 7,675,000 No 4 P Indirect By Corporation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2010-02-01 20,000 $0.21 7,695,000 No 4 P Indirect By Corporation
Common Stock, Par Value $0.0001 Per Share Disposition 2011-01-28 20,000 $0.95 7,675,000 No 4 P Indirect By Corporation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2011-02-16 7,500 $0.79 7,682,500 No 4 P Indirect By Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Corporation
No 4 P Indirect By Corporation
No 4 P Indirect By Corporation
No 4 P Indirect By Corporation
No 4 P Indirect By Corporation
No 4 P Indirect By Corporation
No 4 P Indirect By Corporation
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2007-10-26 10,000 $0.00 10,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-01-26 20,000 $0.00 20,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-04-01 30,000 $0.00 30,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-04-30 40,000 $0.00 40,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-06-02 50,000 $0.00 50,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-06-17 51,500 $0.00 51,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-07-01 61,500 $0.00 61,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-07-01 71,500 $0.00 71,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-09-02 81,500 $0.00 81,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-07-17 83,000 $0.00 83,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-10-31 93,000 $0.00 93,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-10-31 103,000 $0.00 103,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-12-02 113,000 $0.00 113,000 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2008-12-17 114,500 $0.00 114,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2009-01-31 124,500 $0.00 124,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2009-01-31 134,500 $0.00 134,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2009-04-30 144,500 $0.00 144,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2009-04-30 154,500 $0.00 154,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2009-04-30 164,500 $0.00 164,500 $1.00
Common Stock Series 'B' Warrants(Right to Buy) Acquisiton 2009-04-30 166,000 $0.00 166,000 $1.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 2007-03-21 2012-12-31 No 4 J Direct
20,000 2007-06-01 2012-12-31 No 4 J Direct
30,000 2007-08-01 2012-12-31 No 4 J Direct
40,000 2007-12-31 2012-12-31 No 4 J Direct
50,000 2008-04-01 2012-12-31 No 4 J Direct
51,500 2008-07-01 2012-12-31 No 4 J Direct
61,500 2008-10-01 2012-12-31 No 4 J Direct
71,500 2009-01-01 2012-12-31 No 4 J Direct
81,500 2009-04-01 2012-12-31 No 4 J Direct
83,000 2009-04-01 2012-12-31 No 4 J Direct
93,000 2008-10-31 2012-12-31 No 4 J Direct
103,000 2008-10-31 2012-12-31 No 4 J Direct
113,000 2008-12-02 2012-12-31 No 4 J Direct
114,500 2008-12-17 2012-12-31 No 4 J Direct
124,500 2009-01-31 2012-12-31 No 4 J Direct
134,500 2009-01-31 2012-12-31 No 4 J Direct
144,500 2009-04-30 2012-12-31 No 4 J Direct
154,500 2009-04-30 2012-12-31 No 4 J Direct
164,500 2009-04-30 2012-12-31 No 4 J Direct
166,000 2009-04-30 2012-12-31 No 4 J Direct
Footnotes
  1. Warrants acquired by Reporting Person on Transaction Date which should have been reported on a Form 4 by the Reporting Person within 2 business days of the Transaction Date.
  2. Warrants were granted to the Reporting Person in consideration for a $10,000 loan to the Company, bearing interest at 10% per annum and maturing on January 26, 2008.
  3. Warrants were granted to the Reporting Person in consideration for extending the loan listed in footnote (2) above.
  4. Warrants were granted to the Reporting Person in consideration for a $10,000 loan to the Company, bearing interest at 10% per annum and maturing on July 1, 2008.
  5. Warrants were granted to the Reporting Person in consideration for extending the loan listed in footnote (4) above.
  6. Warrants were granted to the Reporting Person in consideration for a $10,000 loan to the Company, bearing interest at 10% per annum and maturing on September 2, 2008.
  7. Warrants were granted to the Reporting Person in consideration for extending the loan listed in footnote (6) above.
  8. Warrants were granted to the Reporting Person in consideration for a $1,500 loan to the Company, bearing interest at 10% per annum and maturing on September 17, 2008.
  9. Warrants were granted to the Reporting Person in consideration for extending the loan listed in footnote (8) above.